Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-17-031953
Filing Date
2017-05-11
Accepted
2017-05-11 17:07:46
Documents
46
Period of Report
2017-02-28

Document Format Files

Seq Description Document Type Size
1 10-K a17-11292_110k.htm 10-K 949941
2 EX-31.1 a17-11292_1ex31d1.htm EX-31.1 10989
3 EX-31.2 a17-11292_1ex31d2.htm EX-31.2 11405
4 EX-32.1 a17-11292_1ex32d1.htm EX-32.1 6275
5 EX-32.2 a17-11292_1ex32d2.htm EX-32.2 6270
  Complete submission text file 0001104659-17-031953.txt   2970730

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20170228.xml EX-101.INS 393247
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20170228.xsd EX-101.SCH 35588
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20170228_cal.xml EX-101.CAL 23966
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20170228_lab.xml EX-101.LAB 273089
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20170228_pre.xml EX-101.PRE 187717
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20170228_def.xml EX-101.DEF 91345
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

EIN.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-K | Act: 34 | File No.: 000-23425 | Film No.: 17835334
SIC: 2835 In Vitro & In Vivo Diagnostic Substances